{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:15:04Z","timestamp":1767651304394},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1053\/j.semnuclmed.2006.03.006","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T13:19:17Z","timestamp":1149772757000},"page":"185-193","source":"Crossref","is-referenced-by-count":52,"title":["Benign Thyroid Disease: What Is the Role of Nuclear Medicine?"],"prefix":"10.1053","volume":"36","author":[{"given":"Salil D.","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2006.03.006_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/thy.1997.7.163","article-title":"Radioiodine and the treatment of hyperthyroidism","volume":"7","author":"Sawin","year":"1997","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib2","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pierce","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib3","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1210\/jc.2002-020524","article-title":"Postpartum thyroiditis","volume":"87","author":"Stagnaro-Green","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib4","series-title":"Diagnostic Nuclear Medicine","first-page":"591","article-title":"Laboratory (in vitro) assessment of thyroid function","author":"Freitas","year":"2003"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib5","first-page":"1073","article-title":"High dose of 131I therapy for the treatment of hyperthyroidism caused by Graves\u2019 disease","volume":"87","author":"Alexander","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/1050725041517011","article-title":"High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves\u2019 disease and silent thyroiditis","volume":"14","author":"Hiraiwa","year":"2004","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib7","series-title":"Principles and Practice of Endocrinology and Metabolism","first-page":"336","article-title":"Thyroid uptake and imaging","author":"Sarkar","year":"2001"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib8","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"IFN \u03b1-related thyroid disease","volume":"88","author":"Carella","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/acta.0.1290031","article-title":"Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies","volume":"129","author":"Vialletes","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/thy.2004.14.1097","article-title":"Graves\u2019 disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection","volume":"14","author":"Jimenez","year":"2004","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis","volume":"55","author":"Miller","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","article-title":"Amiodarone-induced thyrotoxicosis","volume":"86","author":"Daniels","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1089\/1050725041692828","article-title":"Thyroid peroxidase antibodies in early pregnancy","volume":"14","author":"Premawardhana","year":"2004","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198301000-00001","article-title":"Iodide-induced thyrotoxicosis","volume":"62","author":"Fradkin","year":"1983","journal-title":"Medicine"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2265.2004.01978.x","article-title":"On the pathogenesis of autoimmune thyroid disease","volume":"60","author":"Fountoulakis","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease","volume":"343","author":"Weetman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib20","first-page":"747","article-title":"Graves\u2019 ophthalmopathy","volume":"14","author":"Burch","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/er.2004-0005","article-title":"Molecular pathogenesis of euthyroid and toxic multinodular goiter","volume":"26","author":"Krohn","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib22","series-title":"The Pathologic Basis of Nuclear Medicine","article-title":"The thyroid gland","author":"Sarkar","year":"2001"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(83)91217-2","article-title":"Radioiodine-induced thyroid storm","volume":"75","author":"McDermott","year":"1983","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib26","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"Aprospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves\u2019 ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib27","first-page":"3016","article-title":"The effect of antithyroid drug treatment on acute changes in thyroid hormone levels after 131I ablation for Graves\u2019 disease","volume":"86","author":"Burch","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1210\/jcem.86.5.7473","article-title":"Thyroid storm in a child following radioactive iodine (RAI) therapy","volume":"86","author":"Kadmon","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib29","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2002-020580","article-title":"Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves\u2019 disease","volume":"87","author":"Bogazzi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02985106","article-title":"Single dose planning for radioiodine-131 therapy of Graves\u2019 disease","volume":"18","author":"Kita","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00259-002-0877-3","article-title":"Radioiodine therapy in Graves\u2019 disease based on tissue-absorbed dose calculations","volume":"29","author":"Reinhardt","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib32","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1210\/jc.2004-1399","article-title":"Radioactive iodine use in childhood Graves\u2019 disease","volume":"89","author":"Rivkees","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/105072502753522365","article-title":"The effect of methimazole on cure rates after radioiodine treatment for Graves\u2019 hyperthyroidism","volume":"12","author":"Braga","year":"2002","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib35","first-page":"4701","article-title":"Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients","volume":"85","author":"Biondi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib36","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/jc.2002-021046","article-title":"The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities","volume":"88","author":"Sgarbi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib38","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2003-031089","article-title":"Risk of ischemic heart disease and all-cause mortality in subclinical hypothyroidism","volume":"89","author":"Imaizumi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2265.2004.02088.x","article-title":"Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years","volume":"61","author":"Kvetny","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.294.1.71","article-title":"Thyroid function and mortality in patients treated for hyperthyroidism","volume":"294","author":"Franklyn","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2265.2005.02218.x","article-title":"Radioactive iodine therapy often results in hypothyroidism in patients with hyperfunctioning thyroid adenomas","volume":"62","author":"Ceccarelli","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib43","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1210\/jc.2004-0247","article-title":"Propylthiouracil before 131I therapy of hyperthyroid disease","volume":"89","author":"Bonnema","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/1050725041517093","article-title":"Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves\u2019 disease","volume":"14","author":"Santos","year":"2004","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-121-10-199411150-00005","article-title":"Large, compressive goiters treated with radioiodine","volume":"121","author":"Huysmans","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib46","first-page":"3636","article-title":"The feasibility of high dose iodine-131 treatment as an alternative to surgery in patients with a very large goiter","volume":"84","author":"Bonnema","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2265.2003.01918.x","article-title":"Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters","volume":"60","author":"Silva","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib48","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/jc.2004-0458","article-title":"Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine","volume":"90","author":"Albino","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib49","first-page":"146","article-title":"Inadvertent I-131 therapy for hyperthyroidism in the first trimester of pregnancy","volume":"17","author":"Stoffer","year":"1975","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib50","first-page":"2926","article-title":"Thyrotropin receptor antibodies and Graves\u2019 disease, a side effect of I-131 treatment in patients with nontoxic goiter","volume":"82","author":"Nygaard","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib51","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-142-11-200506070-00011","article-title":"Continuing controversies in the management of thyroid nodules","volume":"142","author":"Castro","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib52","series-title":"Benign thyroid disease, in Life Long Learning and Self Assessment Program, Endocrinology Module","author":"Sarkar","year":"2006"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2006.16.109","article-title":"Management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"16","author":"Cooper","year":"2006","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib54","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U","article-title":"Microcarcinoma of the thyroid gland\u2014the Gustav-Roussy Institute experience","volume":"83","author":"Baudin","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072503321669875","article-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","volume":"13","author":"Ito","year":"2003","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib56","series-title":"Werner and Ingbar\u2019s Thyroid","first-page":"889","article-title":"Carcinoma of follicular epithelium","author":"Schneider","year":"2005"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib57","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1148\/radiol.2373050220","article-title":"Management of thyroid nodules detected at ultrasound","volume":"237","author":"Frates","year":"2005","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/jcem.87.5.8504","article-title":"Risk of malignancy in nonpalpable thyroid nodules","volume":"87","author":"Papini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/105072503321669893","article-title":"Autonomous thyroid nodules visualized by positron emission tomography with 18F-fluorodeoxyglucose","volume":"13","author":"Gianoukakis","year":"2003","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib60","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.surg.2005.08.031","article-title":"Preoperative evaluation of thyroid nodules with 18FDG-PET\/CT","volume":"138","author":"Mitchell","year":"2005","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib61","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1542\/peds.91.6.1203","article-title":"Newborn screening for congenital hypothyroidism","volume":"91","year":"1993","journal-title":"Pediatrics"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib62","first-page":"683","volume":"114","author":"Schoen","year":"2004","journal-title":"The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism"},{"issue":"suppl","key":"10.1053\/j.semnuclmed.2006.03.006_bib63","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S1096-6374(03)00055-8","article-title":"Management of hypo- and hyperthyroidism during pregnancy","volume":"13","author":"Glinoer","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/eje.0.1500265","article-title":"Potent thyrotropin receptor-blocking antibodies","volume":"150","author":"Evans","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib65","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1210\/jc.2003-030665","article-title":"Central congenital hypothyroidism due to gestational hyperthyroidism","volume":"88","author":"Kempers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.006_bib66","first-page":"795","article-title":"The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves\u2019 disease","volume":"78","author":"Roti","year":"1994","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:24:40Z","timestamp":1683480280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299806000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0001299806000201"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2006.03.006","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}